<p>Atria Investments Inc 在第一季度根據最新提交給證券交易委員會（SEC）的 13F 申報文件，購入了 HCA Healthcare, Inc.（紐約證券交易所：HCA - Free Report）的新股份。該公司購入了價值約 1,379,000 美元的 4,135 股公司股票。</p>
<p>獲取 <strong>HCA Healthcare</strong> 警報：</p>
<ul>
<li>醫療保健股票乘着急性服務現象飆升至新高</li>
</ul>
<p>其他幾家機構投資者最近也買入和賣出了該股的股票。Swedbank AB 在第一季度購入了 HCA Healthcare 的新股份，價值約 95,882,000 美元。Virtu Financial LLC 在第一季度購入了 HCA Healthcare 的新股份，價值約 537,000 美元。Heartland Bank &amp; Trust Co 在第一季度購入了 HCA Healthcare 的新股份，價值約 215,000 美元。Plato Investment Management Ltd 在第一季度將其在 HCA Healthcare 的持股增加了 665.9%。Plato Investment Management Ltd 現在擁有該公司的 3,140 股股票，價值 1,047,000 美元，比上一季度增加了 2,730 股。最後，Vista Investment Partners LLC 在第一季度將其在 HCA Healthcare 的持股增加了 1.7%。Vista Investment Partners LLC 現在擁有該公司的 7,963 股股票，價值 2,656,000 美元，比上一季度增加了 130 股。目前 62.73% 的股份由機構投資者持有。</p>
<h2>內部人士押注</h2>
<p>另外，高級副總裁 Jeffrey E. Cohen 在 5 月 9 日星期四的交易中出售了公司股票的 1,650 股。股票以平均價格 313.00 美元出售，總價值為 516,450.00 美元。交易完成後，這位高級副總裁現在直接持有公司 5,185 股股票，價值約 1,622,905 美元。該交易已在提交給證券交易委員會的文件中披露，在 SEC 網站上可以查看。另外，高級副總裁 Jeffrey E. Cohen 在 5 月 9 日星期四進行的交易中出售了公司股票的 1,650 股。股票以平均價格 313.00 美元出售，總交易額為 516,450.00 美元。交易完成後，這位高級副總裁現在直接持有公司 5,185 股股票，價值約 1,622,905 美元。該交易已在提交給證券交易委員會的法律文件中披露，可以通過此超鏈接訪問。此外，執行副總裁 Michael S. Cuffe 在 5 月 9 日星期四的交易中出售了公司股票的 6,311 股。股票以平均價格 316.88 美元出售，總價值為 1,999,829.68 美元。交易完成後，這位執行副總裁現在持有公司 29,624 股股票，價值約 9,387,253.12 美元。此次交易的披露可以在此處找到。過去 90 天內，內部人士共出售了價值 6,309,885 美元的 18,668 股公司股票。內部人士持有公司股份的比例為 1.60%。</p>
<h2>HCA Healthcare 股票表現</h2>
<p>紐約證券交易所的 HCA 股票在週二的午盤交易中上漲了 6.86 美元，達到 357.04 美元。該公司的股票交易量為 149,072 股，相比平均交易量 1,159,466 股。HCA Healthcare, Inc.的一年最低價為 215.96 美元，最高價為 369.41 美元。該公司的市值為 935.1 億美元，市盈率為 17.47，市盈增長比率為 1.39，貝塔係數為 1.68。該公司的流動比率為 1.06，速動比率為 0.94，負債權益比率為 27.11。股票的五十日移動平均價格為 334.83 美元，兩百日移動平均價格為 325.15 美元。</p>
<p>HCA Healthcare（紐約證券交易所：HCA - Get Free Report）上次發佈季度收益報告是在 7 月 23 日星期二。公司報告季度每股收益 5.50 美元，超過分析師預期的 4.97 美元，超出 0.53 美元。該公司在本季度的營收為 174.9 億美元，而分析師預期為 170.5 億美元。HCA Healthcare 的淨利潤率為 8.40%，淨資產收益率為 553.13%。該季度業務收入同比增長了 10.3%。在去年同期，該公司的業務收入為每股 4.29 美元。研究分析師平均預測，HCA Healthcare, Inc.本財年將實現每股 22.43 美元的收益。</p>
<h2>HCA Healthcare 宣佈股息</h2>
<p>該公司最近宣佈了季度股息，將於 9 月 30 日星期一支付。截至 9 月 16 日星期一的股東將獲得每股 0.66 美元的股息。這代表年化 2.64 美元的股息和股息率為 0.74%。除息日為 9 月 16 日星期一。HCA Healthcare 的股息支付比率為 13.16%。</p>
<h2>分析師升級和降級</h2>
<p>HCA 最近成為多份研究報告的熱門話題。Robert W. Baird 在 5 月 30 日星期四的一份報告中開始對 HCA Healthcare 進行覆蓋。他們給予該股票&#34;表現優異&#34;的評級，並設定了 396.00 美元的股價目標。摩根大通在 5 月 30 日星期四的一份報告中將 HCA Healthcare 的股價目標從 327.00 美元上調至 332.00 美元，並給予公司&#34;中性&#34;評級。SVB Leerink 在 7 月 24 日星期三的一份報告中將 HCA Healthcare 的股價目標從 367.00 美元上調至 396.00 美元，並給予公司&#34;表現優異&#34;的評級。巴克萊將 HCA Healthcare 的目標股價從 376.00 美元上調至 396.00 美元，並給予公司&#34;超配&#34;評級。最後，富國銀行將 HCA Healthcare 的股價目標從 315.00 美元上調至 365.00 美元，並在 7 月 30 日星期二的一份研究報告中給予該股&#34;等權重&#34;評級。四位研究分析師對該股票給予持有評級，十三位分析師給予買入評級，兩位分析師給予強烈買入評級。根據 MarketBeat 的數據，該公司目前的平均評級為&#34;中等買入&#34;，平均目標股價為 344.06 美元。</p>
<p><strong>閲讀我們關於 HCA 的最新研究報告</strong></p>
<h2>HCA Healthcare 簡介（免費報告）</h2>
<p>HCA Healthcare, Inc.通過其子公司在美國擁有並經營醫院及相關醫療機構。它經營提供醫療和外科服務的綜合急救醫院，包括住院護理、重症監護、心臟護理、診斷和急診服務；以及門診服務，如門診手術、實驗室、放射學、呼吸治療、心臟病學和物理治療。</p>
<h2>精選故事</h2>
<ul>
<li>五支我們比 HCA Healthcare 更看好的股票</li>
<li>什麼是盈利驚喜？</li>
<li>Hims &amp; Hers 報告出色季度：股票預計將上漲</li>
<li>如何使用 MarketBeat Excel 股息計算器</li>
<li>Cloudflare 股票因業績超預期和提高指引而大漲</li>
<li>如何投資生物科技股</li>
<li>Palantir 股票因業績強勁而大漲：30 美元太低嗎？</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUhDQQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUhDQQ"/></p>
<p><em>這則即時新聞警報是由 MarketBeat 的敍事科技和金融數據生成，旨在為讀者提供最快速和準確的報道。本故事在發佈前經過 MarketBeat 編輯團隊的審核。請將有關本故事的任何問題或評論發送至 contact@marketbeat.com.</em></p>
<p>→ 我們在 2016 年推薦了英偉達，現在我們推薦這個...（來自 Porter &amp; Company）（廣告）</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD05MDY2?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD05MDY2"/></p>
<h2>您現在是否應該投資 1000 美元在 HCA Healthcare？</h2>
<p>在考慮 HCA Healthcare 之前，您會想聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街評級最高、表現最佳的研究分析師以及他們向客户推薦的股票。MarketBeat 已經確定了五支頂級分析師悄悄告訴他們的客户在更廣泛市場注意之前現在買入的股票... 而 HCA Healthcare 不在名單上。</p>
<p>儘管 HCA Healthcare 目前在分析師中有&#34;中等買入&#34;評級，但頂級分析師認為這五支股票更值得購買。</p>
<p>查看這五支股票</p>

HCA控股

<p>Atria Investments Inc 已購買了 4,135 股 HCA Healthcare, Inc.的股份。該股份價值約為$1,379,000。其他機構投資者最近也買入和賣出了該股票。內部人士已經出售了大量公司股票。HCA Healthcare 的股票表現積極。公司最近宣佈了季度股息</p>

<p>Atria Investments Inc bought a new stake in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 4,135 shares of the company's stock, valued at approximately $1,379,000.</p>
<div class="lb-trans"><p>Atria Investments Inc 在第一季度根據最新提交給證券交易委員會（SEC）的 13F 申報文件，購入了 HCA Healthcare, Inc.（紐約證券交易所：HCA - Free Report）的新股份。該公司購入了價值約 1,379,000 美元的 4,135 股公司股票。</p>
</div><p>Get <strong>HCA Healthcare</strong> alerts:</p>
<ul>
<li>Healthcare Stock Rides the Acute Services Phenomenon to New Highs</li>
</ul>
<div class="lb-trans"><p>獲取 <strong>HCA Healthcare</strong> 警報：</p>
<ul>
<li>醫療保健股票乘着急性服務現象飆升至新高</li>
</ul>
</div><p>Several other institutional investors also recently bought and sold shares of the stock. Swedbank AB acquired a new stake in shares of HCA Healthcare in the first quarter valued at about $95,882,000. Virtu Financial LLC acquired a new stake in HCA Healthcare during the first quarter worth about $537,000. Heartland Bank &amp; Trust Co acquired a new stake in HCA Healthcare during the first quarter worth about $215,000. Plato Investment Management Ltd grew its position in HCA Healthcare by 665.9% during the first quarter. Plato Investment Management Ltd now owns 3,140 shares of the company's stock worth $1,047,000 after buying an additional 2,730 shares in the last quarter. Finally, Vista Investment Partners LLC grew its position in HCA Healthcare by 1.7% during the first quarter. Vista Investment Partners LLC now owns 7,963 shares of the company's stock worth $2,656,000 after buying an additional 130 shares in the last quarter. 62.73% of the stock is currently owned by institutional investors.</p>
<div class="lb-trans"><p>其他幾家機構投資者最近也買入和賣出了該股的股票。Swedbank AB 在第一季度購入了 HCA Healthcare 的新股份，價值約 95,882,000 美元。Virtu Financial LLC 在第一季度購入了 HCA Healthcare 的新股份，價值約 537,000 美元。Heartland Bank &amp; Trust Co 在第一季度購入了 HCA Healthcare 的新股份，價值約 215,000 美元。Plato Investment Management Ltd 在第一季度將其在 HCA Healthcare 的持股增加了 665.9%。Plato Investment Management Ltd 現在擁有該公司的 3,140 股股票，價值 1,047,000 美元，比上一季度增加了 2,730 股。最後，Vista Investment Partners LLC 在第一季度將其在 HCA Healthcare 的持股增加了 1.7%。Vista Investment Partners LLC 現在擁有該公司的 7,963 股股票，價值 2,656,000 美元，比上一季度增加了 130 股。目前 62.73% 的股份由機構投資者持有。</p>
</div><h2>Insiders Place Their Bets</h2>
<div class="lb-trans"><h2>內部人士押注</h2>
</div><p>In other news, SVP Jeffrey E. Cohen sold 1,650 shares of the company's stock in a transaction on Thursday, May 9th. The stock was sold at an average price of $313.00, for a total value of $516,450.00. Following the completion of the sale, the senior vice president now directly owns 5,185 shares in the company, valued at approximately $1,622,905. The transaction was disclosed in a document filed with the Securities &amp; Exchange Commission, which is available at the SEC website. In other news, SVP Jeffrey E. Cohen sold 1,650 shares of the company's stock in a transaction that occurred on Thursday, May 9th. The stock was sold at an average price of $313.00, for a total transaction of $516,450.00. Following the sale, the senior vice president now directly owns 5,185 shares of the company's stock, valued at approximately $1,622,905. The sale was disclosed in a legal filing with the Securities &amp; Exchange Commission, which can be accessed through this hyperlink. Also, EVP Michael S. Cuffe sold 6,311 shares of the business's stock in a transaction that occurred on Thursday, May 9th. The shares were sold at an average price of $316.88, for a total value of $1,999,829.68. Following the transaction, the executive vice president now owns 29,624 shares of the company's stock, valued at approximately $9,387,253.12. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 18,668 shares of company stock valued at $6,309,885. Insiders own 1.60% of the company's stock.</p>
<div class="lb-trans"><p>另外，高級副總裁 Jeffrey E. Cohen 在 5 月 9 日星期四的交易中出售了公司股票的 1,650 股。股票以平均價格 313.00 美元出售，總價值為 516,450.00 美元。交易完成後，這位高級副總裁現在直接持有公司 5,185 股股票，價值約 1,622,905 美元。該交易已在提交給證券交易委員會的文件中披露，在 SEC 網站上可以查看。另外，高級副總裁 Jeffrey E. Cohen 在 5 月 9 日星期四進行的交易中出售了公司股票的 1,650 股。股票以平均價格 313.00 美元出售，總交易額為 516,450.00 美元。交易完成後，這位高級副總裁現在直接持有公司 5,185 股股票，價值約 1,622,905 美元。該交易已在提交給證券交易委員會的法律文件中披露，可以通過此超鏈接訪問。此外，執行副總裁 Michael S. Cuffe 在 5 月 9 日星期四的交易中出售了公司股票的 6,311 股。股票以平均價格 316.88 美元出售，總價值為 1,999,829.68 美元。交易完成後，這位執行副總裁現在持有公司 29,624 股股票，價值約 9,387,253.12 美元。此次交易的披露可以在此處找到。過去 90 天內，內部人士共出售了價值 6,309,885 美元的 18,668 股公司股票。內部人士持有公司股份的比例為 1.60%。</p>
</div><h2>HCA Healthcare Stock Performance</h2>
<ul>
<li>Top 4 Must-Have Healthcare Stocks for Long-Term Growth</li>
</ul>
<div class="lb-trans"><h2>HCA Healthcare 股票表現</h2>
</div><p>Shares of NYSE HCA traded up $6.86 during midday trading on Tuesday, hitting $357.04. The company's stock had a trading volume of 149,072 shares, compared to its average volume of 1,159,466. HCA Healthcare, Inc. has a one year low of $215.96 and a one year high of $369.41. The firm has a market capitalization of $93.51 billion, a price-to-earnings ratio of 17.47, a P/E/G ratio of 1.39 and a beta of 1.68. The company has a current ratio of 1.06, a quick ratio of 0.94 and a debt-to-equity ratio of 27.11. The stock has a fifty day moving average price of $334.83 and a 200 day moving average price of $325.15.</p>
<div class="lb-trans"><p>紐約證券交易所的 HCA 股票在週二的午盤交易中上漲了 6.86 美元，達到 357.04 美元。該公司的股票交易量為 149,072 股，相比平均交易量 1,159,466 股。HCA Healthcare, Inc.的一年最低價為 215.96 美元，最高價為 369.41 美元。該公司的市值為 935.1 億美元，市盈率為 17.47，市盈增長比率為 1.39，貝塔係數為 1.68。該公司的流動比率為 1.06，速動比率為 0.94，負債權益比率為 27.11。股票的五十日移動平均價格為 334.83 美元，兩百日移動平均價格為 325.15 美元。</p>
</div><p>HCA Healthcare (NYSE:HCA - Get Free Report) last released its quarterly earnings results on Tuesday, July 23rd. The company reported $5.50 EPS for the quarter, beating analysts' consensus estimates of $4.97 by $0.53. The firm had revenue of $17.49 billion during the quarter, compared to analyst estimates of $17.05 billion. HCA Healthcare had a net margin of 8.40% and a return on equity of 553.13%. The business's revenue for the quarter was up 10.3% on a year-over-year basis. During the same period in the previous year, the business earned $4.29 EPS. On average, research analysts forecast that HCA Healthcare, Inc. will post 22.43 EPS for the current fiscal year.</p>
<div class="lb-trans"><p>HCA Healthcare（紐約證券交易所：HCA - Get Free Report）上次發佈季度收益報告是在 7 月 23 日星期二。公司報告季度每股收益 5.50 美元，超過分析師預期的 4.97 美元，超出 0.53 美元。該公司在本季度的營收為 174.9 億美元，而分析師預期為 170.5 億美元。HCA Healthcare 的淨利潤率為 8.40%，淨資產收益率為 553.13%。該季度業務收入同比增長了 10.3%。在去年同期，該公司的業務收入為每股 4.29 美元。研究分析師平均預測，HCA Healthcare, Inc.本財年將實現每股 22.43 美元的收益。</p>
</div><h2>HCA Healthcare Announces Dividend</h2>
<ul>
<li>These are the Top 4 Stocks for Buybacks in 2024</li>
</ul>
<div class="lb-trans"><h2>HCA Healthcare 宣佈股息</h2>
</div><p>The firm also recently announced a quarterly dividend, which will be paid on Monday, September 30th. Shareholders of record on Monday, September 16th will be paid a dividend of $0.66 per share. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.74%. The ex-dividend date is Monday, September 16th. HCA Healthcare's dividend payout ratio is 13.16%.</p>
<div class="lb-trans"><p>該公司最近宣佈了季度股息，將於 9 月 30 日星期一支付。截至 9 月 16 日星期一的股東將獲得每股 0.66 美元的股息。這代表年化 2.64 美元的股息和股息率為 0.74%。除息日為 9 月 16 日星期一。HCA Healthcare 的股息支付比率為 13.16%。</p>
</div><h2>Analyst Upgrades and Downgrades</h2>
<div class="lb-trans"><h2>分析師升級和降級</h2>
</div><p>HCA has been the topic of a number of recent research reports. Robert W. Baird initiated coverage on HCA Healthcare in a report on Thursday, May 30th. They set an &#34;outperform&#34; rating and a $396.00 price objective on the stock. JPMorgan Chase &amp; Co. lifted their price objective on HCA Healthcare from $327.00 to $332.00 and gave the company a &#34;neutral&#34; rating in a report on Thursday, May 30th. SVB Leerink lifted their price objective on HCA Healthcare from $367.00 to $396.00 and gave the company an &#34;outperform&#34; rating in a report on Wednesday, July 24th. Barclays lifted their target price on shares of HCA Healthcare from $376.00 to $396.00 and gave the company an &#34;overweight&#34; rating in a research note on Wednesday, July 24th. Finally, Wells Fargo &amp; Company boosted their price objective on shares of HCA Healthcare from $315.00 to $365.00 and gave the stock an &#34;equal weight&#34; rating in a research report on Tuesday, July 30th. Four research analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and two have assigned a strong buy rating to the company's stock. According to MarketBeat, the company currently has an average rating of &#34;Moderate Buy&#34; and an average target price of $344.06.</p>
<div class="lb-trans"><p>HCA 最近成為多份研究報告的熱門話題。Robert W. Baird 在 5 月 30 日星期四的一份報告中開始對 HCA Healthcare 進行覆蓋。他們給予該股票&#34;表現優異&#34;的評級，並設定了 396.00 美元的股價目標。摩根大通在 5 月 30 日星期四的一份報告中將 HCA Healthcare 的股價目標從 327.00 美元上調至 332.00 美元，並給予公司&#34;中性&#34;評級。SVB Leerink 在 7 月 24 日星期三的一份報告中將 HCA Healthcare 的股價目標從 367.00 美元上調至 396.00 美元，並給予公司&#34;表現優異&#34;的評級。巴克萊將 HCA Healthcare 的目標股價從 376.00 美元上調至 396.00 美元，並給予公司&#34;超配&#34;評級。最後，富國銀行將 HCA Healthcare 的股價目標從 315.00 美元上調至 365.00 美元，並在 7 月 30 日星期二的一份研究報告中給予該股&#34;等權重&#34;評級。四位研究分析師對該股票給予持有評級，十三位分析師給予買入評級，兩位分析師給予強烈買入評級。根據 MarketBeat 的數據，該公司目前的平均評級為&#34;中等買入&#34;，平均目標股價為 344.06 美元。</p>
</div><p><strong>Read Our Latest Research Report on HCA</strong></p>
<div class="lb-trans"><p><strong>閲讀我們關於 HCA 的最新研究報告</strong></p>
</div><h2>HCA Healthcare Profile (Free Report)</h2>
<div class="lb-trans"><h2>HCA Healthcare 簡介（免費報告）</h2>
</div><p>HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.</p>
<div class="lb-trans"><p>HCA Healthcare, Inc.通過其子公司在美國擁有並經營醫院及相關醫療機構。它經營提供醫療和外科服務的綜合急救醫院，包括住院護理、重症監護、心臟護理、診斷和急診服務；以及門診服務，如門診手術、實驗室、放射學、呼吸治療、心臟病學和物理治療。</p>
</div><h2>Featured Stories</h2>
<ul>
<li>Five stocks we like better than HCA Healthcare</li>
<li>What is an Earnings Surprise?</li>
<li>Hims &amp; Hers Reports Stellar Quarter: Stock Set for a Rally</li>
<li>How to Use the MarketBeat Excel Dividend Calculator</li>
<li>Cloudflare Stock Flares Up on Solid EPS Beat and Raised Guidance</li>
<li>How to Invest in Biotech Stocks</li>
<li>Palantir Stock Surges After Strong Earnings: Is $30 Too Low?</li>
</ul>
<div class="lb-trans"><h2>精選故事</h2>
<ul>
<li>五支我們比 HCA Healthcare 更看好的股票</li>
<li>什麼是盈利驚喜？</li>
<li>Hims &amp; Hers 報告出色季度：股票預計將上漲</li>
<li>如何使用 MarketBeat Excel 股息計算器</li>
<li>Cloudflare 股票因業績超預期和提高指引而大漲</li>
<li>如何投資生物科技股</li>
<li>Palantir 股票因業績強勁而大漲：30 美元太低嗎？</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUhDQQ" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=HCA"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>這則即時新聞警報是由 MarketBeat 的敍事科技和金融數據生成，旨在為讀者提供最快速和準確的報道。本故事在發佈前經過 MarketBeat 編輯團隊的審核。請將有關本故事的任何問題或評論發送至 contact@marketbeat.com.</em></p>
</div><p>→ We recommended Nvidia in 2016, now we’re recommending this… (From Porter &amp; Company)(Ad)</p>
<div class="lb-trans"><p>→ 我們在 2016 年推薦了英偉達，現在我們推薦這個...（來自 Porter &amp; Company）（廣告）</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD05MDY2" alt="" original-src="https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx?TriggeredCampaignID=9066&amp;Placement=NativeDisplay&amp;Source=NativeDisplay"/></p>
<h2>Should you invest $1,000 in HCA Healthcare right now?</h2>
<div class="lb-trans"><h2>您現在是否應該投資 1000 美元在 HCA Healthcare？</h2>
</div><p>Before you consider HCA Healthcare, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮 HCA Healthcare 之前，您會想聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HCA Healthcare wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街評級最高、表現最佳的研究分析師以及他們向客户推薦的股票。MarketBeat 已經確定了五支頂級分析師悄悄告訴他們的客户在更廣泛市場注意之前現在買入的股票... 而 HCA Healthcare 不在名單上。</p>
</div><p>While HCA Healthcare currently has a &#34;Moderate Buy&#34; rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>儘管 HCA Healthcare 目前在分析師中有&#34;中等買入&#34;評級，但頂級分析師認為這五支股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看這五支股票</p>
</div>

Atria Investments Inc 購買了 4,135 股 HCA 控股（紐約證券交易所代碼：HCA）的股票